Tirzepatide
Commons · Question 10140 · Tabled 21 Oct 2024 · Department of Health and Social Care · Official record
Answered 30 Oct 2024
Question
Asked by Lee Anderson
To ask the Secretary of State for Health and Social Care, with reference to his Department's press release entitled Landmark collaboration with largest pharmaceutical company, published on 14 October 2024, how many times will a patient be allowed to take
Answer
Answered by Andrew Gwynne, 30 Oct 2024
As announced on 14 October 2024, the SURMOUNT-REAL clinical trial of tirzepatide, brand name Mounjaro, is being developed between Health Innovation Manchester, The University of Manchester, and Eli Lilly and Company, with further details about the study t...